Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
Keywords :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
location
Contact Email
Phone number
Website URL
Similar Companies1000
Sagimet Biosciences
Sagimet Biosciences develops novel therapeutics to treat metabolic diseases and specific cancers.
Sector
Subsector
Keywords
Location
total rounds
total raised
VBL THERAPEUTICS
VBL Therapeutics is a clinical stage biotech company that develops innovative treatments for cancer and immune-inflammatory diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
MBX Biosciences
MBX Biosciences creates therapies to treat rare endocrine diseases.
Sector
Subsector
Location
total rounds
total raised
Theraclone Sciences
Theraclone Sciences develops innovative therapeutic antibodies for infectious diseases and inflammation.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds12
Number of Funding Rounds
Money Raised
Their latest funding was raised on 27.03.2024. Their latest round Post-IPO Equity
Co-Investors
Investors4
Number of lead investors
Number of investors
Maurice Zauderer
Maurice Zauderer, Ph.D. has served as Vaccinex's President and Chief Executive Officer and a member ofboard of directors since its inception in April 2001. Prior to founding the company, Dr. Zauderer was an Associate Professor at the University of Rochester and has also held senior faculty positions at Columbia University. During his academic career, Dr. Zauderer held the position of visiting scientist at the Laboratory of Cell Biology, the Ontario Cancer Institute and the National Cancer Institute. Dr. Zauderer received a B.S. in Physics from Yeshiva University and a Ph.D. in Cell Biology from the Massachusetts Institute of Technology.
current job
count Of Investments
Jacob Frieberg
Jacob B. Frieberg has served as a member of Vaccinex's board of directors since February 2015. Mr. Frieberg has also served as a principal at The WTF Group, a Toronto-based property management company, since founding the company in 1984. Prior to that time, he was the Vice President at Rockford Developments, a Calgary-based multi-family building company. Mr. Frieberg received a B.A. in Economics from the University of Western Ontario. Mr. Frieberg’s experience in business, including his management responsibility, gives him the qualifications, skills and financial expertise to serve on Vaccinex's board of directors.
count Of Investments
Alzheimer's Drug Discovery Foundation
The Alzheimer’s Drug Discovery Foundation finds drugs for Alzheimer’s disease.
Sector
Subsector
Location
count Of Investments
count Of Exists
People
Founders2
Maurice Zauderer
Maurice Zauderer, Ph.D. has served as Vaccinex's President and Chief Executive Officer and a member ofboard of directors since its inception in April 2001. Prior to founding the company, Dr. Zauderer was an Associate Professor at the University of Rochester and has also held senior faculty positions at Columbia University. During his academic career, Dr. Zauderer held the position of visiting scientist at the Laboratory of Cell Biology, the Ontario Cancer Institute and the National Cancer Institute. Dr. Zauderer received a B.S. in Physics from Yeshiva University and a Ph.D. in Cell Biology from the Massachusetts Institute of Technology.
current job
count Of Investments
Maurice Zauderer
Steven Cobourn
Steven P. Cobourn has served as our Chief Financial Officer since May 2014. From December 2003 to April 2014, Mr. Cobourn was the Vice President of Finance and Treasurer of Otsuka America Pharmaceutical, Inc., Otsuka Pharmaceutical Development & Commercialization, Inc. and Otsuka Maryland Medicinal Laboratories, Inc., each a subsidiary of Otsuka Holdings Co., Ltd., a Japanese publicly traded pharmaceutical company. Prior to this, Mr. Cobourn served in various roles at these Otsuka entities in finance and corporate planning. He was also a certified public accountant at accounting firm Hass & Company LLC. Mr. Cobourn received a B.S. in Business Administration from Drexel University.
current job
organization founded
Steven Cobourn
Employee Profiles13
Loretta Mueller
Senior manager, laboratory operations and safety
John Parker
Vice president, regulatory affairs and quality systems
Activity
Recent News3
The graph reveals the ratio (%) of positive news articles in a chosen time range